Ionis Pharmaceuticals' late-stage clinical trial of a cardiac drug failed, and the company's stock price fell 7%.

Zhitongcaijing · 1d ago
Ionis Pharmaceuticals' late-stage clinical trial of a cardiac drug failed, and the company's stock price fell 7%.